Mazankowski Alberta Heart Institute (MAHI) EchoGo Discovery 1 Protocol

Ultromics

Status: Unknown

Conditions: Cardiotoxicity; Cancer

Treatments: Device: EchoGo

Study type: Observational

Funder types: Industry; Other

Identifiers

NCT04877899

COL-04

Details and patient eligibility

About

This study aims to compare conventionally acquired Left Ventricle Ejection Fraction (LVEF) and Global Longitudinal Strain (GLS) data to Artificial Intelligence (AI) driven automated processing of 2 dimensional contrast and 2 dimensional non-contrast resting transthoracic echocardiograms for application in the assessment of patients undergoing chemotherapy with cardiotoxic drugs. This is a single-centre retrospective study which utilizes echocardiographic DICOM image and meta-data datasets received from a Canadian site. Data processed using the AI driven automated processing will be compared to conventionally acquired LVEF and GLS measurements and results will be analysed to determine accuracy and precision.

Enrollment: 250 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Normal EF and no regional wall motion abnormalities prior to starting chemotherapy treatment.
• Follow-up EF measurements available for at least 1 year during the treatment period.
• Follow-up EF measurements for at least 1 year during the treatment period.

Exclusion criteria

• Age < 18 years
• Inadequate image quality (as determined by the Ultromics Operators Quality Control process)